An early trial hints that psilocybin could be a safe and effective treatment for depressive episodes in bipolar II disorder and should be studied further.
While I’m all for descheduling psilocybin (and decriminalizing it as well), it should be noted that this was a very small sample size study (15 people) and I’ve heard anecdotal warnings to not take shrooms if bipolar or schizophrenic for years, as there might be a slight risk of psychosis.
You also have to take into account the setting the test was administered in. The participants underwent therapy before, during, and after the treatment. Being in a safe space with immediate access to mental health professionals probably decreases the risks substantially.
While I’m all for descheduling psilocybin (and decriminalizing it as well), it should be noted that this was a very small sample size study (15 people) and I’ve heard anecdotal warnings to not take shrooms if bipolar or schizophrenic for years, as there might be a slight risk of psychosis.
You also have to take into account the setting the test was administered in. The participants underwent therapy before, during, and after the treatment. Being in a safe space with immediate access to mental health professionals probably decreases the risks substantially.